Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis (Q24187707)

4

object named as

William J Sandborn

0 references

author name string

Siddharth Singh

1

0 references

Andrea M Stroud

2

0 references

Stefan D Holubar

3

0 references

Darrell S Pardi

Cochrane Database of Systematic Reviews

5

0 references

publication date

23 November 2015

0 references

published in

0 references

cites work

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Allopurinol as prophylaxis against pouchitis following ileal pouch-anal anastomosis for ulcerative colitis. A randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Budesonide enema in pouchitis--a double-blind, double-dummy, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Enteral inulin does not affect epithelial gene expression and cell turnover within the ileoanal pouch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Budesonide in the treatment of inflammatory bowel disease: the first year of experience in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Use of Biologics in Pouchitis: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Dysfunction of the continent ileostomy: clinical features and bacteriology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Role of oxygen free radicals in the etiology of pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Systematic review: the management of pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Ileitis and pouchitis after colectomy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Infliximab for the treatment of pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Oral budesonide in the treatment of chronic refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Clinical guidelines for the management of pouchitis

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

1 reference

7 January 2021

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

1 reference

7 January 2021

Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Mucosal enteritis: a complication of the continent ileostomy

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Short-chain fatty acids in pouch contents from patients with and without pouchitis after ileal pouch-anal anastomosis

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Endoscopic assessment of acute inflammation of the ileal reservoir after restorative ileo-anal anastomosis.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Long‐term efficacy of bismuth carbomer enemas in patients with treatment‐resistant chronic pouchitis

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Increased mucosal levels of leukotriene B4 in pouchitis: evidence for a persistent inflammatory state

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001176.PUB3

7 January 2021

10.1002/14651858.CD001176.PUB3

Identifiers

DOI

1 reference

1 reference

1 reference

PubMed publication ID

26593456

1 reference